NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-50 Cr | ₹-19 Cr | ₹12 Cr | ₹30 Cr | ₹41 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of NATCO PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-50 Cr |
| Mar2024 | ₹-19 Cr |
| Mar2023 | ₹12 Cr |
| Mar2022 | ₹30 Cr |
| Mar2021 | ₹41 Cr |
How is Deferred Tax Assets / Liabilities of NATCO PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-50 Cr | Negative | |
| Mar2024 | ₹-19 Cr | Negative | |
| Mar2023 | ₹12 Cr | -58.80 | |
| Mar2022 | ₹30 Cr | -27.12 | |
| Mar2021 | ₹41 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹19,480.7 Cr | -3.3% | 7% | 41.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,243.0 Cr | -1.4% | -7.2% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,179.0 Cr | 5.7% | 0.3% | 14.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,670.0 Cr | 1.5% | -6.5% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,932.0 Cr | 0.7% | -7.4% | 9.9% | Stock Analytics | |
| CIPLA | ₹99,417.9 Cr | 0.5% | -7.1% | -14.4% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -3.3% |
7% |
41.5% |
| SENSEX | 0.6% |
1.5% |
6.6% |
You may also like the below Video Courses